Catalyst Pharmaceuticals Inc


Market Cap$1.63B

Compare Catalyst Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Catalyst Pharmaceuticals IncCatalyst Pharmaceuticals Inc26.30%18%7.1-
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

10.5% upside

Undervalued by 10.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.63 Billion
Enterprise Value$1.51 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.55
Outstanding Shares117,564,816
Avg 30 Day Volume1,122,405


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio26.34
Price to Sales7.09
Price to Book Ratio7.09
Enterprise Value to Revenue4.34
Enterprise Value to EBIT19.93
Enterprise Value to Net Income24
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Catalyst Pharmaceuticals Inc

CEO: Patrick McEnany